Acute myeloid leukaemia (AML)

• Personal Stories

The stories behind Teenage and Young Adult Cancer Awareness Month

For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer. For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer.

6 April 2023

• Science & Technology

The link between Down syndrome and childhood leukaemia

In 1930, it was discovered that children with Down syndrome are at a greater risk of developing certain types of leukaemia, but much of our understanding of this link remains a mystery. In 1930, it was discovered that children with Down syndrome are at a greater risk of developing certain types of leukaemia, but much of our understanding of this link remains a mystery.

1 September 2022

• Health & Medicine

Cancer Research UK spin-out gets US approval to trial unique T-cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.   Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.  

18 June 2021

• Science & Technology

Scientists developing new class of drug for leukaemia

Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year.  Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year. 

27 April 2021

• Science & Technology

Antibiotic shows potential in helping treat aggressive blood cancer

New research shows a type of aggressive blood cancer could be made more sensitive to chemotherapy using an antibiotic currently available to treat diarrhoea. New research shows a type of aggressive blood cancer could be made more sensitive to chemotherapy using an antibiotic currently available to treat diarrhoea.

24 February 2021

• Health & Medicine

Targeted treatment for leukaemia approved on NHS in England 

The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.   The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.  

16 July 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Science & Technology

Acute myeloid leukaemia is 11 different diseases

Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms. Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms.

9 June 2016

Traces of cancer cells in blood could warn of acute leukaemia relapse

Researchers showed that the presence of leukaemia cells after initial chemotherapy could predict how well a patient subsequently fared. Researchers showed that the presence of leukaemia cells after initial chemotherapy could predict how well a patient subsequently fared.

20 January 2016

• Science & Technology

Researchers uncover weakness in leukaemia cells

UK scientists have found that a pair of genes inside cells could play a major role in how a serious form of leukaemia develops. UK scientists have found that a pair of genes inside cells could play a major role in how a serious form of leukaemia develops.

11 January 2016

• Science & Technology

New leukaemia gene stops blood cells ‘growing up’

Scientists have identified a gene – FOXC1 – that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukaemia (AML) patients Scientists have identified a gene – FOXC1 – that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukaemia (AML) patients

14 September 2015